110 related articles for article (PubMed ID: 15474367)
1. Recessive, but not dominant, mutations in peripheral myelin protein 22 gene show unique patterns of aggregation and intracellular trafficking.
Liu N; Yamauchi J; Shooter EM
Neurobiol Dis; 2004 Nov; 17(2):300-9. PubMed ID: 15474367
[TBL] [Abstract][Full Text] [Related]
2. Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22.
Tobler AR; Liu N; Mueller L; Shooter EM
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):483-8. PubMed ID: 11752407
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
4. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
5. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
6. Aberrant protein trafficking in Trembler suggests a disease mechanism for hereditary human peripheral neuropathies.
Naef R; Adlkofer K; Lescher B; Suter U
Mol Cell Neurosci; 1997 Jan; 9(1):13-25. PubMed ID: 9204477
[TBL] [Abstract][Full Text] [Related]
7. PMP22 carrying the trembler or trembler-J mutation is intracellularly retained in myelinating Schwann cells.
Colby J; Nicholson R; Dickson KM; Orfali W; Naef R; Suter U; Snipes GJ
Neurobiol Dis; 2000 Dec; 7(6 Pt B):561-73. PubMed ID: 11114256
[TBL] [Abstract][Full Text] [Related]
8. [Molecular genetics of inherited neuropathies].
Takashima H
Rinsho Shinkeigaku; 2006 Jan; 46(1):1-18. PubMed ID: 16541790
[TBL] [Abstract][Full Text] [Related]
9. Developmental abnormalities in the nerves of peripheral myelin protein 22-deficient mice.
Amici SA; Dunn WA; Notterpek L
J Neurosci Res; 2007 Feb; 85(2):238-49. PubMed ID: 17131416
[TBL] [Abstract][Full Text] [Related]
10. Dominant and recessive distal renal tubular acidosis mutations of kidney anion exchanger 1 induce distinct trafficking defects in MDCK cells.
Cordat E; Kittanakom S; Yenchitsomanus PT; Li J; Du K; Lukacs GL; Reithmeier RA
Traffic; 2006 Feb; 7(2):117-28. PubMed ID: 16420521
[TBL] [Abstract][Full Text] [Related]
11. Transport of Trembler-J mutant peripheral myelin protein 22 is blocked in the intermediate compartment and affects the transport of the wild-type protein by direct interaction.
Tobler AR; Notterpek L; Naef R; Taylor V; Suter U; Shooter EM
J Neurosci; 1999 Mar; 19(6):2027-36. PubMed ID: 10066256
[TBL] [Abstract][Full Text] [Related]
12. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
13. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies.
Li J; Ghandour K; Radovanovic D; Shy RR; Krajewski KM; Shy ME; Nicholson GA
Arch Neurol; 2007 Jul; 64(7):974-8. PubMed ID: 17620487
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation.
Beysen D; Moumné L; Veitia R; Peters H; Leroy BP; De Paepe A; De Baere E
Hum Mol Genet; 2008 Jul; 17(13):2030-8. PubMed ID: 18372316
[TBL] [Abstract][Full Text] [Related]
15. Varying survival of motoneurons and activation of distinct molecular mechanism in response to altered peripheral myelin protein 22 gene dosage.
Nattkämper H; Halfter H; Khazaei MR; Lohmann T; Gess B; Eisenacher M; Willscher E; Young P
J Neurochem; 2009 Aug; 110(3):935-46. PubMed ID: 19493167
[TBL] [Abstract][Full Text] [Related]
16. Peripheral myelin protein 22 kDa and protein zero: domain specific trans-interactions.
Hasse B; Bosse F; Hanenberg H; Müller HW
Mol Cell Neurosci; 2004 Dec; 27(4):370-8. PubMed ID: 15555916
[TBL] [Abstract][Full Text] [Related]
17. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
18. Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model.
Fortun J; Li J; Go J; Fenstermaker A; Fletcher BS; Notterpek L
J Neurochem; 2005 Mar; 92(6):1531-41. PubMed ID: 15748170
[TBL] [Abstract][Full Text] [Related]
19. Association of calnexin with mutant peripheral myelin protein-22 ex vivo: a basis for "gain-of-function" ER diseases.
Dickson KM; Bergeron JJ; Shames I; Colby J; Nguyen DT; Chevet E; Thomas DY; Snipes GJ
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9852-7. PubMed ID: 12119418
[TBL] [Abstract][Full Text] [Related]
20. Membrane topology of peripheral myelin protein 22.
Taylor V; Zgraggen C; Naef R; Suter U
J Neurosci Res; 2000 Oct; 62(1):15-27. PubMed ID: 11002284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
